For research use only. Not for therapeutic Use.
Siramesine hydrochloride (CAT: I002725) is a selective sigma-2 receptor agonist. It acts on sigma-2 receptors, found in various cell types, including cancer cells. By activating these receptors, Siramesine hydrochloride can induce cell death through mechanisms like apoptosis and autophagy. This compound has shown promise as an anticancer agent in preclinical studies, exhibiting antitumor effects in lung, breast, and prostate cancer. However, further research and clinical trials are needed to fully understand its therapeutic potential, efficacy, and safety in human patients.
Catalog Number | I002725 |
CAS Number | 224177-60-0 |
Molecular Formula | C30H32ClFN2O |
Purity | ≥95% |
Target | sigma-2 receptor; lysosome-destabilizing agent |
Solubility | DMSO: ≥ 42 mg/mL |
Storage | Store at -20C |
IUPAC Name | 1/'-[4-[1-(4-fluorophenyl)indol-3-yl]butyl]spiro[1H-2-benzofuran-3,4/'-piperidine];hydrochloride |
InChI | InChI=1S/C30H31FN2O.ClH/c31-25-12-14-26(15-13-25)33-21-23(27-9-2-4-11-29(27)33)7-5-6-18-32-19-16-30(17-20-32)28-10-3-1-8-24(28)22-34-30;/h1-4,8-15,21H,5-7,16-20,22H2;1H |
InChIKey | ILSRGIFRZZSGPN-UHFFFAOYSA-N |
SMILES | C1CN(CCC12C3=CC=CC=C3CO2)CCCCC4=CN(C5=CC=CC=C54)C6=CC=C(C=C6)F.Cl |
Reference | <p style=/line-height:25px/> |